# Mast Cell Activation Syndrome (MCAS) Domain - Plan

## Vision

Apply Domain-Driven Design principles to model a comprehensive Mast Cell Activation Syndrome management system that supports diagnostic assessment, trigger management, medication protocols, symptom tracking, specialist coordination, and outcomes measurement.

## Goals

1. Define a ubiquitous language that bridges clinical MCAS expertise with software development terminology.
2. Establish bounded contexts that reflect the natural divisions within MCAS management.
3. Model aggregates, entities, and value objects that capture the complexity of MCAS diagnosis and treatment.
4. Design domain events that enable communication across bounded contexts.
5. Ensure regulatory compliance with healthcare standards including HIPAA, HL7 FHIR, and clinical guidelines.
6. Support evidence-based outcomes measurement and quality-of-life tracking.

## Bounded Contexts

### Diagnostic Assessment Context

Responsible for managing diagnostic criteria, laboratory test results, and clinical evaluation workflows. This context owns the diagnostic journey from initial suspicion through confirmed diagnosis using consensus criteria.

### Trigger Management Context

Handles identification, categorization, and avoidance strategies for MCAS triggers. Covers environmental, dietary, pharmacological, and physiological triggers with personalized avoidance protocols.

### Medication Protocol Context

Manages medication regimens including H1/H2 antihistamines, mast cell stabilizers, leukotriene inhibitors, and compounded medications. Tracks dosing schedules, titration plans, and medication interactions.

### Symptom Tracking Context

Captures multi-system symptom data, flare events, severity scoring, and pattern analysis. Supports longitudinal tracking across dermatological, gastrointestinal, cardiovascular, neurological, and respiratory systems.

### Specialist Coordination Context

Coordinates care among multiple specialists including allergists, immunologists, gastroenterologists, dermatologists, and primary care providers. Manages referrals, shared care plans, and inter-provider communication.

### Outcomes Measurement Context

Measures treatment effectiveness through symptom burden scores, quality-of-life assessments, medication effectiveness metrics, and functional status evaluations. Supports both individual and population-level analysis.

## Strategic Approach

1. Start with the core subdomain (Diagnostic Assessment) as it provides the foundation for all other contexts.
2. Build supporting subdomains (Trigger Management, Medication Protocol, Symptom Tracking) incrementally.
3. Integrate coordination and measurement contexts as the system matures.
4. Use domain events for loose coupling between bounded contexts.
5. Apply anti-corruption layers where integration with external clinical systems is required.

## Milestones

- Milestone 1: Define ubiquitous language and bounded context boundaries.
- Milestone 2: Model core domain aggregates and entities.
- Milestone 3: Design domain events and integration patterns.
- Milestone 4: Document regulatory compliance requirements.
- Milestone 5: Complete tactical design patterns for all bounded contexts.
- Milestone 6: Review, harmonize, and finalize all documentation.

## References

- Evans, Eric. Domain-Driven Design: Tackling Complexity in the Heart of Software. Addison-Wesley, 2003.
- Vernon, Vaughn. Implementing Domain-Driven Design. Addison-Wesley, 2013.
- Khononov, Vlad. Learning Domain-Driven Design. O'Reilly Media, 2021.
- Valent, P. et al. "Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome." Journal of Allergy and Clinical Immunology: In Practice, 2019.
- Afrin, L.B. Never Bet Against Occam: Mast Cell Activation Disease and the Modern Epidemics of Chronic Illness and Medical Complexity. Sisters Media, 2016.
